Safety Study of HPP854 in Subjects With Mild Cognitive Impairment or a Diagnosis of Mild Alzheimer's Disease
Status:
Terminated
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
This is a safety and tolerability study investigating the effect of HPP854 in subjects with
mild cognitive impairment or a diagnosis of mild Alzheimer's disease. The study will assess
the pharmacokinetic and pharmacodynamic relationships of HPP854 in plasma, pharmacodynamic
relationship in cerebral spinal fluid and plasma concentration profiles for Amyloid-Beta.